skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The expanding role of folates and fluoropyrimidines in cancer chemotherapy
The expanding role of folates and fluoropyrimidines in cancer chemotherapy
Material Type:
Livro 		Adicionar ao Meu Espaço

The expanding role of folates and fluoropyrimidines in cancer chemotherapy

International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy (1988 Buffalo, N.Y.) Youcef M Rustum; John J McGuire

New York Plenum Press c1988

Localização: CQ - Conjunto das Químicas    (615.58 S612e )(Acessar)

2
"Valor prognóstico e preditivo da expressão imunoistoquímica de timidilato sintase em pacientes portadores de adenocarcinoma colorretal"
"Valor prognóstico e preditivo da expressão imunoistoquímica de timidilato sintase em pacientes portadores de adenocarcinoma colorretal"
Material Type:
Dissertação de Mestrado 		Adicionar ao Meu Espaço

"Valor prognóstico e preditivo da expressão imunoistoquímica de timidilato sintase em pacientes portadores de adenocarcinoma colorretal"

Aguiar Junior, Samuel

Biblioteca Digital de Teses e Dissertações da USP; Universidade de São Paulo; Faculdade de Medicina 2004-04-02

Acesso online

3
Management of rectal cancer: the 2016 French guidelines
Management of rectal cancer: the 2016 French guidelines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of rectal cancer: the 2016 French guidelines

Lakkis, Z. ; Manceau, G. ; Bridoux, V. ; Brouquet, A. ; Kirzin, S. ; Maggiori, L. ; de Chaisemartin, C. ; Lefevre, J. H. ; Panis, Y.

Colorectal disease, 2017-02, Vol.19 (2), p.115-122 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer

He, Wanming ; Liang, Bishan ; Wang, Chunlin ; Li, Shaowei ; Zhao, Yang ; Huang, Qiong ; Liu, Zexian ; Yao, Zhiqi ; Wu, Qijing ; Liao, Wangjun ; Zhang, Shuyi ; Liu, Yajing ; Xiang, Yi ; Liu, Jia ; Shi, Min

Oncogene, 2019-06, Vol.38 (23), p.4637-4654 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane

Kaufman, Peter A ; Awada, Ahmad ; Twelves, Chris ; Yelle, Louise ; Perez, Edith A ; Velikova, Galina ; Olivo, Martin S ; He, Yi ; Dutcus, Corina E ; Cortes, Javier

Journal of clinical oncology, 2015-02, Vol.33 (6), p.594-601 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Conroy, Thierry ; Bosset, Jean-François ; Etienne, Pierre-Luc ; Rio, Emmanuel ; François, Éric ; Mesgouez-Nebout, Nathalie ; Vendrely, Véronique ; Artignan, Xavier ; Bouché, Olivier ; Gargot, Dany ; Boige, Valérie ; Bonichon-Lamichhane, Nathalie ; Louvet, Christophe ; Morand, Clotilde ; de la Fouchardière, Christelle ; Lamfichekh, Najib ; Juzyna, Béata ; Jouffroy-Zeller, Claire ; Rullier, Eric ; Marchal, Frédéric ; Gourgou, Sophie ; Castan, Florence ; Borg, Christophe ; Borg, Christophe ; Etienne, Pierre-Luc ; Rio, Emmanuel ; Mesgouez-Nebout, Nathalie ; François, Éric ; Vendrely, Véronique ; Conroy, Thierry ; Artignan, Xavier ; Bouché, Olivier ; Gargot, Dany ; Boige, Valérie ; Bonichon-Lamichhane, Nathalie ; Louvet, Christophe ; Morand, Clotilde ; de la Fouchardière, Christelle ; Ronchin, Philippe ; Seitz, Jean-François ; Corbinais, Stéphane ; Maillard, Emmanuel ; Noirclerc, Monique ; El Hajbi, Farid ; Villing, Anne-Laure ; Bécouarn, Yves ; Foong Fat Lam Kam Sang, Lam ; Artru, Pascal ; Bachet, Jean-Baptiste ; Hocine, Fayçal ; Ligeza-Poisson, Catherine ; Vautravers, Claire ; Ben Abdelghani, Meher ; Aparicio, Thomas ; Desot, Elise ; Marquis, Isabelle

The lancet oncology, 2021-05, Vol.22 (5), p.702-715 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Al-Batran, Salah-Eddin ; Homann, Nils ; Pauligk, Claudia ; Goetze, Thorsten O ; Meiler, Johannes ; Kasper, Stefan ; Kopp, Hans-Georg ; Mayer, Frank ; Haag, Georg Martin ; Luley, Kim ; Lindig, Udo ; Schmiegel, Wolff ; Pohl, Michael ; Stoehlmacher, Jan ; Folprecht, Gunnar ; Probst, Stephan ; Prasnikar, Nicole ; Fischbach, Wolfgang ; Mahlberg, Rolf ; Trojan, Jörg ; Koenigsmann, Michael ; Martens, Uwe M ; Thuss-Patience, Peter ; Egger, Matthias ; Block, Andreas ; Heinemann, Volker ; Illerhaus, Gerald ; Moehler, Markus ; Schenk, Michael ; Kullmann, Frank ; Behringer, Dirk M ; Heike, Michael ; Pink, Daniel ; Teschendorf, Christian ; Löhr, Carmen ; Bernhard, Helga ; Schuch, Gunter ; Rethwisch, Volker ; von Weikersthal, Ludwig Fischer ; Hartmann, Jörg T ; Kneba, Michael ; Daum, Severin ; Schulmann, Karsten ; Weniger, Jörg ; Belle, Sebastian ; Gaiser, Timo ; Oduncu, Fuat S ; Güntner, Martina ; Hozaeel, Wael ; Reichart, Alexander ; Jäger, Elke ; Kraus, Thomas ; Mönig, Stefan ; Bechstein, Wolf O ; Schuler, Martin ; Schmalenberg, Harald ; Hofheinz, Ralf D

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1948-1957 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Material Type:
Artigo 		Adicionar ao Meu Espaço

5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future

Vodenkova, Sona ; Buchler, Tomas ; Cervena, Klara ; Veskrnova, Veronika ; Vodicka, Pavel ; Vymetalkova, Veronika

Pharmacology & therapeutics (Oxford), 2020-02, Vol.206, p.107447, Article 107447 [Periódico revisado por pares]

England: Elsevier Inc

Texto completo disponível

Citações Citado por
9
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Conroy, Thierry ; Hammel, Pascal ; Hebbar, Mohamed ; Ben Abdelghani, Meher ; Wei, Alice C ; Raoul, Jean-Luc ; Choné, Laurence ; Francois, Eric ; Artru, Pascal ; Biagi, James J ; Lecomte, Thierry ; Assenat, Eric ; Faroux, Roger ; Ychou, Marc ; Volet, Julien ; Sauvanet, Alain ; Breysacher, Gilles ; Di Fiore, Frédéric ; Cripps, Christine ; Kavan, Petr ; Texereau, Patrick ; Bouhier-Leporrier, Karine ; Khemissa-Akouz, Faiza ; Legoux, Jean-Louis ; Juzyna, Béata ; Gourgou, Sophie ; O’Callaghan, Christopher J ; Jouffroy-Zeller, Claire ; Rat, Patrick ; Malka, David ; Castan, Florence ; Bachet, Jean-Baptiste

The New England journal of medicine, 2018-12, Vol.379 (25), p.2395-2406 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh ; Ross, Paul J ; Ma, Yuk Ting ; Arora, Arvind ; Falk, Stephen ; Gillmore, Roopinder ; Wadsley, Jonathan ; Patel, Kinnari ; Anthoney, Alan ; Maraveyas, Anthony ; Iveson, Tim ; Waters, Justin S ; Hobbs, Claire ; Barber, Safia ; Ryder, W David ; Ramage, John ; Davies, Linda M ; Bridgewater, John A ; Valle, Juan W

The lancet oncology, 2021-05, Vol.22 (5), p.690-701 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (26.053)
  2. magazinearticle  (53)
  3. Anais de Congresso  (16)
  4. Livros  (5)
  5. Book Chapters  (2)
  6. Reports  (1)
  7. Produções Acadêmicas  (1)
  8. Newsletter Articles  (1)
  9. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1973  (738)
  2. 1973Até1984  (2.370)
  3. 1985Até1996  (5.259)
  4. 1997Até2009  (9.292)
  5. Após 2009  (8.513)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (21.440)
  2. Japonês  (4.611)
  3. Alemão  (616)
  4. Francês  (541)
  5. Chinês  (460)
  6. Russo  (373)
  7. Italiano  (214)
  8. Espanhol  (122)
  9. Polonês  (61)
  10. Português  (39)
  11. Húngaro  (34)
  12. Coreano  (26)
  13. Holandês  (21)
  14. Dinamarquês  (20)
  15. Tcheco  (19)
  16. Norueguês  (18)
  17. Hebraico  (18)
  18. Romeno  (9)
  19. Ucraniano  (9)
  20. Búlgaro  (9)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.